Clinical trials in neuromodulatory treatment of drug-resistant hypertension and the need for spinal cord stimulation trials: a PRISMA systematic review

Clinical trials in neuromodulatory treatment of drug-resistant hypertension and the need for spinal cord stimulation trials: a PRISMA systematic review

Abstract Background Drug-resistant hypertension affects approximately 9–18% of the United States hypertensive population. Recognized as hypertension that is resistant to three or more medications, drug-resistant hypertension can lead to fatal sequelae, such as heart failure, aortic dissection, and o...

Full description

Saved in:
Bibliographic Details
Main Authors: Garrett W. Thrash, Elijah Wang, Yifei Sun, Harrison C. Walker, Prasad Shirvalkar, Bryan K. Becker, Marshall T. Holland
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Bioelectronic Medicine
Subjects:
Neuromodulation
Spinal Cord Stimulation
SCS
Drug resistant Hypertension
Hypertension
Renal Denervation
Online Access:https://doi.org/10.1186/s42234-024-00160-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s42234-024-00160-7

Similar Items